Healthcare & Life Sciences
Mediar Therapeutics
United Stateswww.mediartx.com
Mediar Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
activeseries-b
series-b
Stage
2
Investors
About Mediar Therapeutics
Mediar Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Mediar Therapeutics is a clinical-stage biotechnology company developing first-in-class antibody therapies designed to halt and reverse fibrosis by targeting key fibrotic mediator proteins that drive disease progression in chronically damaged organs.
Explore Mediar Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.